Investigation of dose related effects of propolis on anxiety and some biochemical parameters with sympathetic skin response and increased T-maze
Abstract
Methods: Forty Wistar albino male rats were used in the study, divided into four groups: The control group, low dose (10 mg/kg PRO), medium dose (30 mg/kg PRO) and high dose propolis groups (50 mg/kg PRO). Propolis was administered via gavage to all rats except the control group. Twenty minutes after injection, the anxiety scores of the rats were evaluated with an elevated T-maze, and their electrodermal activities (EDA) were measured. At the end of the experiment, some enzymatic and lipid values were measured with malondialdehyde (MDA) in blood samples.
Results: The percentage of time spent on open arms and the number of open arm entries were lower in the 10mg/kg PRO group, while an increase was observed in the 30 mg/kg PRO group. EDA values were lower in the 30 mg / kg PRO (P=0.012; P=0.02, respectively) and 50 mg / kg PRO (P=0.013, P=0.02, respectively) groups as compared to the control group. MDA was significantly lower in the 30 mg/kg PRO and 50 mg/kg PRO groups. While AST value increased in the 30 mg / kg PRO group, ALT value decreased. Total cholesterol and triglyceride values were significantly lower in the 50 mg / kg PRO group. HDL value increased significantly after administration of propolis and LDL value decreased significantly only in the 10 mg/kg PRO group.
Conclusions: According to the results obtained by EDA and T labyrinth methods, while low and high dose propolis, which was administered to rats after cold stress, showed an anxiogenic effect, medium dose propolis exerted an anxiolytic effect. It also decreased MDA values in the medium and high dose groups and influenced enzymatic and lipid values in favor of the rat. It was concluded that the anxiety-related effects of propolis were dose-dependent.
Keywords
Destekleyen Kurum
Proje Numarası
Kaynakça
- 1. Gupta D, Radhakrishnan M, Kurhe. Anxiolytic-like effects of alverine citrate in experimental Mouse models of anxiety. European Journal of Pharmacology. 2014;742:94–101.
- 2. Kalueff AV, Wheaton M, Murphy DL. What's wrong with my mouse model: advances and strategies in animal modeling of anxiety and depression. Behav Brain Res. 2007;179:1–18.
- 3. Griebel G, Holmes A. 50 years of hurdles and hope in anxiolytic drug discovery. Nat. Rev Drug Discov. 2013;12:667–87.
- 4. Prut L, Belzung C. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol. 2003;463:3–33.
- 5. Dolu N, Keloglan S, Bitiktas S, Cug S. The effects of the enriched environment on sympathetic skin response in pentylenetetrazol-kindled rats. Biomed Environ Sci. 2013;26(5):394–7.
- 6. Andor T, Gerlach AL, Rist F. Superior perception of phasic physiological arousal and the detrimental consequences of the conviction to be aroused on worrying and metacognitions in GAD. J Abnorm Psychol. 2008;117:193–205.
- 7. Bradley MM, Codispoti M, Cuthbert BN, Lang PJ. Emotion and motivation I: defensive and appetitive reactions in picture processing. Emotion. 2001;1:276–98.
- 8. Naccache L, Dehaene S, Cohen L, Habert MO, Guichart Gomez E, Galanaud D. Effortless control: executive attention and conscious feeling of mental effort are dissociable. Neuropsychologia. 2005;43:1318–28.
Ayrıntılar
Birincil Dil
İngilizce
Konular
Biyokimya ve Hücre Biyolojisi (Diğer)
Bölüm
Araştırma Makalesi
Yazarlar
Mustafa Nisari
*
0000-0001-7469-8921
Türkiye
Memet Emre
Bu kişi benim
0000-0001-8695-5913
Türkiye
Nazan Dolu
Bu kişi benim
0000-0002-3104-7587
Türkiye
Hale Acer
Bu kişi benim
0000-0002-7823-2034
Türkiye
Ferhat Pektaş
0000-0002-1862-9515
Türkiye
Yayımlanma Tarihi
1 Mayıs 2020
Gönderilme Tarihi
23 Nisan 2020
Kabul Tarihi
27 Mayıs 2020
Yayımlandığı Sayı
Yıl 2020 Cilt: 4 Sayı: 5
Cited By
BAZI HASTALIKLARIN ÖNLENMESİ VE BESLENME DESTEK TEDAVİSİNDE PROPOLİS KULLANIMI
Veteriner Farmakoloji ve Toksikoloji Derneği Bülteni
https://doi.org/10.38137/vftd.962340